CD8A and breast carcinoma: Nevertheless, this finding should not be overrated, as this statistically significant result was not robust when adding the CD8 results and survival data of breast carcinomas of our first cohort (Log-Rank p = 0.1538, Wilcoxon p = 0.2665).